Batch KE25012 of Abhayrab Rabies Vaccine was found not to be of standard quality during testing. The government increased monitoring of distribution.
Questions over quality of Abhayrab's KE25012 batch; The drug regulator asked the states to be cautious.
New Delhi. India's drug regulator approves approval of widely used rabies vaccine Abhayrab One batch has been found 'not of standard quality' after testing.
under investigation batch KE25012 A sample did not meet the required potency standards. Differences were also found in the packaging, QR code and labeling from the reference sample, after which it is being investigated for authenticity.
The drug controller has asked state regulators to keep a close watch on the supply and distribution of this batch.
At present it is not clear how many doses of this batch reached the market. If a person has been exposed to rabies, do not take the decision to stop or change the vaccine on your own; Medical advice is necessary.